While competition from Amazon Bazaar and Flipkart’s Shopsy remains a key risk, analysts believe Meesho’s "everyday-low-price" ...

Indian pharmaceutical market (IPM) has registered a growth of 8.1 percent to touch ₹2,40,672 crore in 2025 and is likely to ...

Meesho share price rebounds 5% to ₹173 after a three-day decline, attributed to the end of a lock-in period for pre-IPO ...

Agarwal joined Meesho in 2020 and took over as CXO, business in October 2023 after succeeding Utkrishta Kumar; the company ...

After a dramatic session yesterday, today the Indian markets closed in the blues of the Nifty expiry day volatility. Although ...

The shares of Meesho dropped another 5 percent on January 7 to near its listing price after the company announced that its ...

Meesho co-founder and CEO, Vidit Aatrey, officially joined the billionaire club following the company's highly successful stock market listing. Meesho’s shares soared on their debut day, jumping ...

Mumbai: After a powerful rally following its stock market listing, shares of e-commerce platform Meesho have now seen a sharp correction. On Monday, the stock slipped to Rs 201.68 and hit the lower ...

The financial terms of the deal were not disclosed. Based in the Chicago area, Go Raw positions itself as a “better-for-you” ...

Meesho shares rally 20 per cent to Rs 216.34 as UBS initiates coverage with Rs 220 target; Anil Singhvi cites strong post-IPO momentum, highlighting rising annual transacting users and potential ...

Meesho’s sharp post-IPO rally has lost momentum as valuation concerns, lock-in expiry-related selling and cautious brokerage ...

Shares of Meesho climbed 8 per cent in Wednesday's trade after foreign brokerage UBS reportedly initiated coverage the stock with a 'Buy' rating and a target price of Rs 220 apiece, saying the company ...